Depressive Disorder News and Research

RSS

How has the COVID-19 pandemic affected mental health?

In this interview, we spoke to Dr. Damian Santomauro and Dr. Alize Ferrari about their latest research into COVID-19 and its impact on mental health.

19 Oct 2021

Johns Hopkins Medicine awarded NIH grant to explore the impacts of psilocybin on tobacco addiction

Johns Hopkins Medicine was awarded a grant from the National Institutes of Health (NIH) to explore the potential impacts of psilocybin on tobacco addiction.

18 Oct 2021

Experts review progress in using photobiomodulation therapy to treat diverse brain disorders

Photobiomodulation (PBM) offers exciting opportunities for improving the life of patients with a diverse range of brain disorders.

14 Oct 2021

Wrist accelerometer data reveals how sleep is disrupted in mental illness

Multiple measures of sleep patterns and sleep efficiency are associated with lifetime diagnoses of mental illness, according to a new study that used wrist accelerometer data to track sleep.

12 Oct 2021

Study reveals the global impacts of the pandemic on major depressive and anxiety disorders

Cases of major depressive disorder and anxiety disorders increased by more than a quarter worldwide in 2020 due to the COVID-19 pandemic, according to the first global estimates of impacts of the pandemic on mental health, published in The Lancet.

11 Oct 2021

Study reveals rising rates of depressive and anxiety disorders due to COVID-19 pandemic

Cases of major depressive disorder and anxiety disorders have increased by more than 25 per cent worldwide, according to a world-first study of the impact of COVID-19 on mental health.

8 Oct 2021

Saliva test could be used for lithium monitoring among patients with mood disorders

Lithium is a common medication prescribed to patients with psychiatric disorders, namely bipolar disorder, schizophrenia, and depression.

4 Oct 2021

Scientists link insulin resistance to increased risk of developing major depressive disorder

Stanford Medicine scientists have linked insulin resistance to an increased risk of developing a major depressive disorder.

29 Sep 2021

Insulin resistance linked to an increased risk of major depressive disorder

Stanford Medicine scientists have linked insulin resistance to an increased risk of developing major depressive disorder.

23 Sep 2021

Study finds cognitive safety of ketamine and esketamine for patients with treatment-resistant depression

Used for the treatment of depression that does not respond to standard antidepressant medications, the anesthesia drug ketamine – and the related drug esketamine, recently approved for depression treatment – has no important adverse effects on memory, attention, or other cognitive processes, concludes a systematic review of medical research in the September/October issue of Harvard Review of Psychiatry.

12 Aug 2021

Canadians with a history of drug dependence more likely to have mental illness, finds study

New research published online in the International Journal of Mental Health and Addiction found that Canadians with a history of drug dependence are much less likely to have flourishing mental health and are more likely to have mental illness.

14 Jul 2021

Study: 57.8% of healthcare professionals suffered mental disorders during COVID-19 first wave

A study on 149 healthcare professionals in Spain and Mexico reveals that, during the first wave of the COVID-19 pandemic, 57.8% of them suffered from mental disorders such as anxiety, acute stress and depression.

12 Jul 2021

Many coal miners suffering from black lung disease struggle with mental-health issues

More than a third of coal miners and former coal miners suffering from black lung disease struggle with depression, and more than one in 10 has recently considered suicide, a new study finds.

8 Jul 2021

New project aims to identify quantitative biological features common across diseases

Building on the success of innovative research by the PRISM project, the Innovative Medicine Initiative 2, a joint undertaking between the EU and the European Federation of Pharmaceutical Industries and Associations (EFPIA), has backed the program with funding for a new project to explore the underlying biology of Alzheimer's disease, schizophrenia and Major Depressive Disorder (MDD).

23 Jun 2021

Study reveals the interplay between proteins that control the body's stress response

The biological mechanisms behind stress-related psychiatric conditions, including major depressive disorder and post-traumatic stress disorder (PTSD), are poorly understood.

21 Jun 2021

UIC discovery may lead to new treatments for alcohol use disorder and depression

A discovery from researchers at the University of Illinois Chicago may lead to new treatments for individuals who suffer from alcohol use disorder and depression.

14 Jun 2021

Adolescents with higher levels of omega-3 fatty acids less likely to develop psychotic disorder

New research has found that adolescents with higher levels of an omega-3 fatty acid in their blood were less likely to develop psychotic disorder in early adulthood, suggesting that it may have a potential preventative effect of reducing the risk of psychosis.

1 Jun 2021

Waking up just one hour earlier can reduce risk of major depression, indicates study

Waking up just one hour earlier could reduce a person's risk of major depression by 23%, suggests a sweeping new genetic study published May 26 in the journal JAMA Psychiatry.

29 May 2021

Genomic study identifies marked differences between two halves of the hippocampus

A study of gene activity in the brain's hippocampus, led by UT Southwestern researchers, has identified marked differences between the region's anterior and posterior portions. The findings, published today in Neuron, could shed light on a variety of brain disorders that involve the hippocampus and may eventually help lead to new, targeted treatments.